Last update 22 Dec 2024
Recombinant human interferon gamma adenovirus ( Guangzhou DoublleBioproduct)
Last update 22 Dec 2024
Overview
Basic Info
Drug Type Gene therapy |
Synonyms E10B |
Target |
Mechanism IFNγ stimulants(Interferon gamma stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Recombinant human interferon gamma adenovirus ( Guangzhou DoublleBioproduct)一项开放性、剂量递增的I期临床研究，评估E10B在晚期去势抵抗性前列腺癌患者中单次给药的安全性、耐受性和初步疗效
[Translation] An open-label, dose-escalation Phase I study evaluating the safety, tolerability, and preliminary efficacy of a single dose of E10B in patients with advanced castration-resistant prostate cancer
100 Clinical Results associated with Recombinant human interferon gamma adenovirus ( Guangzhou DoublleBioproduct)
Login to view more data
100 Translational Medicine associated with Recombinant human interferon gamma adenovirus ( Guangzhou DoublleBioproduct)
Login to view more data
100 Patents (Medical) associated with Recombinant human interferon gamma adenovirus ( Guangzhou DoublleBioproduct)
Login to view more data
261
Literatures (Medical) associated with Recombinant human interferon gamma adenovirus ( Guangzhou DoublleBioproduct)11 Mar 2023Voprosy virusologii
[In vitro activity of human recombinant interferon gamma against SARS-CoV-2 virus].
Article
Author: Nikolaeva, Y V ; Berns, S A ; Galochkina, A V ; Shtro, A A
20 Dec 2022BMJ Open
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.
Article
Author: Netea, Mihai G ; Wiersinga, W Joost ; Weis, Sebastian ; Slim, Marleen A ; Vlaar, Alexander P J ; Antonakos, Nikolaos ; Müller, Marcella C A ; van Mourik, Niels ; Lupse, Mihaela ; Bakkerus, Lieke ; Bauer, Michael ; Kotsaki, Antigone ; Meylan, Sylvain ; Calandra, Thierry ; van Vught, Lonneke ; Bloos, Frank ; Giamarellos-Bourboulis, Evangelos J ; Pickkers, Peter ; van der Poll, Tom ; de Nooijer, Aline
01 Jan 2020OncoimmunologyQ2 · MEDICINE
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells
Q2 · MEDICINE
ArticleOA
Author: Rosato, Antonio ; Carpanese, Debora ; Cappuzzello, Elisa ; Dalla Pietà, Anna ; Sommaggio, Roberta ; Palmerini, Pierangela ; Nicolè, Lorenzo ; Tosi, Anna
100 Deals associated with Recombinant human interferon gamma adenovirus ( Guangzhou DoublleBioproduct)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Castration-Resistant Prostatic Cancer | Phase 1 | CN | 28 Dec 2022 | |
| Liver Cancer | IND Application | CN | 20 Aug 2006 | |
| Nasopharyngeal Neoplasms | IND Application | CN | 20 Aug 2006 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free